CN1264591A - Medicine for treating psoriasis and preparing process thereof - Google Patents
Medicine for treating psoriasis and preparing process thereof Download PDFInfo
- Publication number
- CN1264591A CN1264591A CN 99101474 CN99101474A CN1264591A CN 1264591 A CN1264591 A CN 1264591A CN 99101474 CN99101474 CN 99101474 CN 99101474 A CN99101474 A CN 99101474A CN 1264591 A CN1264591 A CN 1264591A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- rhizoma
- medicine
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A medicine in the form of pill for treating is prepared from 17 Chinese-medicinal materials including raw rehmannia root, scorpion, American ginseng, Chinese angelica root, arnebia root, etc. through washing, drying in sun, grinding, sieving, mixing, pilling, sterilization, and drying. It features high curative effect.
Description
The present invention relates to the psoriatic medicine of a kind of treatment, is the Chinese patent medicine of feedstock production with the Chinese herbal medicine specifically, the invention still further relates to the preparation method of this medicine.
Psoriasis has another name called " psoriasis ", is a kind of chronic inflammatory disease dermatoses of common and easy recurrence.Primary disease is many because of feelings will internal injury, obstruction of QI, and strongly fragrant fire-transformation of a specified duration, hyperactivity of heart-fire, scorchingly hot lying prostrate in nutrient blood fallen ill; Or because of intemperance of taking food, the surfeit raw meat is sent out food, and taste are become estranged, functional activity of QI being not smooth, and strongly fragrant heat-transformation of a specified duration, multiple wind-engaging pyretic toxicity is evil and fall ill, if for a long time or outbreak repeatedly, then cloudy blood is consumed, the passages through which vital energy circulates retardance, QI and blood is condensed, failure of skin and muscle to be nourished.
Psoriatic symptom shows on patient's the skin, and skin surface is based on pimple, or based on squama, erythema, chickenpox or abscess etc. arranged.The skin lesion pilosity is born in scalp, eyebrow and ear, trunk and extremity, and have the seborrheic dermatitis characteristic, this presentation is the external cutaneous manifestations of internal organs noxious dampness.Ancients transfer: have in the small piece of land surrounded by water, must a shape small piece of land surrounded by water outside.General description the relation of body internal organs and body surface.
To the Drug therapy of primary disease, majority is only paid attention to appearance skin medicine for external use at present, does not start with from interior therapeutic, though symptom takes a turn for the better recurrence easily sometimes.There is not pure Chinese medicinal preparation treatment psoriasis on the market.
Doctor trained in Western medicine is used bimolane, viaminate capsule when whole body therapeutic, hormone medicines such as Bang Lidiwei capsule are for oral administration, and side effect is big.
The purpose of this invention is to provide a kind of blood circulation promoting and blood stasis dispelling that has, removing pathogenic heat from blood and toxic substance from the body, expelling wind and removing dampness, heat-clearing and toxic substances removing makes deflorescence, the psoriatic medicine of treatment that erythema silver bits disappear.
Another object of the present invention provides the preparation method of this curing psoriasis medicine.
Solution of the present invention is to think according to theory of Chinese medical science, the lung is concerned with QI of the whole body, and department breathes, towards hundred arteries and veins, close skin at body, its Hua Zaimao, the treatment psoriasis will be sent out lung qi by a surname, encourages the pore of fur open, so that noxious dampness is passed through inside, detoxification and promoting urination by intracorporeal organ again, noxious dampness is just excreted as early as possible by two, work along both lines like this, the heresy of noxious dampness is eliminated, human body skin just keeps normal condition naturally, and psoriasis can be fully recovered.
Medicine of the present invention is made (consumption is a weight portion) by following component:
Radix Rehmanniae 4-8 part Scorpio 3-7 part Radix Panacis Quinquefolii 8-16 part
Radix Angelicae Sinensis 4-8 part Thallus Porphyrae 6-10 part Rhizoma Smilacis Glabrae 8-16 part
Cortex Dictamni 3-7 part Radix Clematidis 3-7 part Zaocys 4-8 part
Living Flos Sophorae Immaturus 3-7 part Fructus Mume 3-7 part Rhizoma Curcumae 3-7 part
Rhizoma Imperatae 3-7 part Radix Salviae Miltiorrhizae 3-7 part Indigo Naturalis 3-7 part
Rhizoma Coptidis 1.5-4 part Radix Glycyrrhizae 2-6 part
The formula optimization weight proportion scope of preparation medicine of the present invention is:
Radix Rehmanniae 5-7 part Scorpio 4-6 part Radix Panacis Quinquefolii 10-14 part
Radix Angelicae Sinensis 5-7 part Radix Arnebiae (Radix Lithospermi) 7-9 part Rhizoma Smilacis Glabrae 10-14 part
Cortex Dictamni 4-6 part Radix Clematidis 4-6 part Zaocys 5-7 part
Living Flos Sophorae Immaturus 4-6 part Fructus Mume 4-6 part Rhizoma Curcumae 4-6 part
Rhizoma Imperatae 4-6 part Radix Salviae Miltiorrhizae 4-6 part Indigo Naturalis 4-6 part
Rhizoma Coptidis 2-3 part Radix Glycyrrhizae 3-5 part
The optimum weight proportioning of medicine of the present invention is:
12 parts of 5 parts of Radix Panacis Quinquefoliis of 6 portions of Scorpios of Radix Rehmanniae
12 parts of 8 parts of Rhizoma Smilacis Glabraes of 6 portions of Radix Arnebiae (Radix Lithospermi)s of Radix Angelicae Sinensis
6 parts of 5 parts of Zaocyss of 5 parts of Radix Clematidis of Cortex Dictamni
5 parts of 5 parts of Rhizoma Curcumae of 5 portions of Fructus Mumes of the living Flos Sophorae Immaturus
5 parts of 5 parts of Indigo Naturaliss of 5 parts of Radix Salviae Miltiorrhizaes of Rhizoma Imperatae
4 parts in 2.5 portions of Radix Glycyrrhizaes of Rhizoma Coptidis
The psoriatic medicine of treatment of the present invention, its said medicament are piece agent or pill or powder.
Above-mentioned each component is made medicine production method of the present invention is:
Get each raw material and clean respectively, dry, be broken into fine powder, cross 80 mesh standard sieves, mixing, water pill, sterilization, drying, packing, finished product.
In the medicine material of the present invention, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Rhizoma Curcumae are blood circulation promoting and blood stasis dispelling; Radix Rehmanniae, Radix Arnebiae (Radix Lithospermi), the living Flos Sophorae Immaturus, Rhizoma Coptidis, Rhizoma Imperatae are the removing pathogenic heat from blood and toxic substance from the body medicine; Scorpio, Zaocys, Radix Clematidis are Medicine for the treatment of rheumatism and arthritis; Indigo Naturalis, Cortex Dictamni, Rhizoma Smilacis Glabrae, Radix Glycyrrhizae, heat-clearing and toxic substances removing.Share mutual promoting action together.
Medicine of the present invention is through 40 routine curing psoriasis, criterion of therapeutical effect: complete: deflorescence, and erythema silver bits disappear, and the full recovery normal skin does not see that new erythra occurs.Produce effects: deflorescence is more than 50%, and the erythra that Shang Weijian is new occurs.Effectively: more than the deflorescence 10-20%, do not see that new erythra occurs.Invalid: erythra is not seen and is disappeared or erythra still continues to enlarge and increases.
The present invention's 40 routine treatment targets: male's 22 examples, women's 18 examples, at minimum 10 years old of age, maximum 42 years old, the course of disease is the shortest 3 months, and was the longest 17 years.Occupation: workman 20 people wherein, peasant 4 people, cadre 8 people, commercial 2 people, student 5 people, teacher 1 people.
Therapeutic outcome: psoriasis (psoriasis) 40 examples, complete more 37 examples of treatment, effective 2 examples, invalid 1 example, total effective rate 98% is treated effective patient and is taken effect with interior treatment 30 days mostly, does not see other side effect at period in a medicine.
The present invention prepares embodiment:
Take by weighing raw material by following proportioning:
30 kilograms of 12 kilograms of Radix Panacis Quinquefoliis of 15 kilograms of Scorpios of Radix Rehmanniae
30 kilograms of 20 kilograms of Rhizoma Smilacis Glabraes of 15 kilograms of Radix Arnebiae (Radix Lithospermi)s of Radix Angelicae Sinensis
15 kilograms of 12 kilograms of Zaocyss of 12 kilograms of Radix Clematidis of Cortex Dictamni
12 kilograms of 12 kilograms of Rhizoma Curcumae of 12 kilograms of Fructus Mumes of the living Flos Sophorae Immaturus
12 kilograms of 12 kilograms of Indigo Naturaliss of 12 kilograms of Radix Salviae Miltiorrhizaes of Rhizoma Imperatae
10 kilograms in 6 kilograms of Radix Glycyrrhizaes of Rhizoma Coptidis
Production method is as follows:
Get each raw medicinal material respectively and clean, dry, be broken into fine powder, cross 80 mesh standard sieves, advance Drug Manufacturing Room and produce (cleaning shop, ten thousand grades of inside and outside preparations), mixing, water pill is placed on the sterile chamber with water pill, sterilizes drying, packing, finished product 45 minutes for ten thousand grades.Be named the compound recipe Xiaoyinwan pill, adopt pure Chinese medicine preparation, every bottle 36 gram, oral every day three times, each 6 grams take with boiled water.
Claims (5)
1, the psoriatic medicine of a kind of treatment is characterized in that it is the medicament of being made by the following weight proportion raw material
Radix Rehmanniae 4-8 part Scorpio 3-7 part Radix Panacis Quinquefolii 8-16 part
Radix Angelicae Sinensis 4-8 part Radix Arnebiae (Radix Lithospermi) 6-10 part Rhizoma Smilacis Glabrae 8-16 part
Cortex Dictamni 3-7 part Radix Clematidis 3-7 part Zaocys 4-8 part
Living Flos Sophorae Immaturus 3-7 part Fructus Mume 3-7 part Rhizoma Curcumae 3-7 part
Rhizoma Imperatae 3-7 part Radix Salviae Miltiorrhizae 3-7 part Indigo Naturalis 3-7 part
Rhizoma Coptidis 1.5-4 part Radix Glycyrrhizae 2-6 part
2, the psoriatic medicine of treatment as claimed in claim 1, wherein the weight proportion of each raw material is
Radix Rehmanniae 5-7 part Scorpio 4-6 part Radix Panacis Quinquefolii 10-14 part
Radix Angelicae Sinensis 5-7 part Radix Arnebiae (Radix Lithospermi) 7-9 part Rhizoma Smilacis Glabrae 10-14 part
Cortex Dictamni 4-6 part Radix Clematidis 4-6 part Zaocys 5-7 part
Living Flos Sophorae Immaturus 4-6 part Fructus Mume 4-6 part Rhizoma Curcumae 4-6 part
Rhizoma Imperatae 4-6 part Radix Salviae Miltiorrhizae 4-6 part Indigo Naturalis 4-6 part
Rhizoma Coptidis 2-3 part Radix Glycyrrhizae 3-5 part
3, the psoriatic medicine of treatment as claimed in claim 1, wherein the weight proportion of each raw material is
12 parts of 5 parts of Radix Panacis Quinquefoliis of 6 portions of Scorpios of Radix Rehmanniae
12 parts of 8 parts of Rhizoma Smilacis Glabraes of 6 portions of Radix Arnebiae (Radix Lithospermi)s of Radix Angelicae Sinensis
6 parts of 5 parts of Zaocyss of 5 parts of Radix Clematidis of Cortex Dictamni
5 parts of 5 parts of Rhizoma Curcumae of 5 portions of Fructus Mumes of the living Flos Sophorae Immaturus
5 parts of 5 parts of Indigo Naturaliss of 5 parts of Radix Salviae Miltiorrhizaes of Rhizoma Imperatae
4 parts in 2.5 portions of Radix Glycyrrhizaes of Rhizoma Coptidis
4,, it is characterized in that said medicament is piece agent or pill or powder as claim 1 or the psoriatic medicine of 2 or 3 described treatments.
5, the preparation method of the psoriatic medicine of treatment as claimed in claim 4 is characterized in that getting each raw material and cleans respectively, dries, and is broken into fine powder, crosses 80 mesh standard sieves, mixing, water pill, sterilization, drying, packing, finished product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99101474 CN1108810C (en) | 1999-02-26 | 1999-02-26 | Medicine for treating psoriasis and preparing process thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99101474 CN1108810C (en) | 1999-02-26 | 1999-02-26 | Medicine for treating psoriasis and preparing process thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1264591A true CN1264591A (en) | 2000-08-30 |
| CN1108810C CN1108810C (en) | 2003-05-21 |
Family
ID=5270462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 99101474 Expired - Fee Related CN1108810C (en) | 1999-02-26 | 1999-02-26 | Medicine for treating psoriasis and preparing process thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1108810C (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005094861A1 (en) * | 2004-04-02 | 2005-10-13 | Sung-Bae Park | Composition for treating psoriasis-associated diseases |
| CN1318067C (en) * | 2005-10-27 | 2007-05-30 | 李文 | Medicine for treating teenage's acne |
| CN100353970C (en) * | 2004-08-27 | 2007-12-12 | 闫晓东 | Psoriasis treating Chinese medicine prepn and its pren process |
| CN102210828A (en) * | 2011-06-03 | 2011-10-12 | 祖冲 | Chinese medicine capsule for treating psoriasis |
| CN102274437A (en) * | 2011-08-31 | 2011-12-14 | 刘巧 | Blood poison eliminating capsules |
| CN104189228A (en) * | 2014-08-02 | 2014-12-10 | 吴俊贤 | Medicine ointment for treating psoriasis, as well as preparation method and application thereof |
| CN105381026A (en) * | 2015-12-24 | 2016-03-09 | 兰州古驰生物科技有限公司 | Traditional Chinese medicine health-care preparation used for conditioning allergic state of skin |
-
1999
- 1999-02-26 CN CN 99101474 patent/CN1108810C/en not_active Expired - Fee Related
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005094861A1 (en) * | 2004-04-02 | 2005-10-13 | Sung-Bae Park | Composition for treating psoriasis-associated diseases |
| CN100353970C (en) * | 2004-08-27 | 2007-12-12 | 闫晓东 | Psoriasis treating Chinese medicine prepn and its pren process |
| CN1318067C (en) * | 2005-10-27 | 2007-05-30 | 李文 | Medicine for treating teenage's acne |
| CN102210828A (en) * | 2011-06-03 | 2011-10-12 | 祖冲 | Chinese medicine capsule for treating psoriasis |
| CN102274437A (en) * | 2011-08-31 | 2011-12-14 | 刘巧 | Blood poison eliminating capsules |
| CN104189228A (en) * | 2014-08-02 | 2014-12-10 | 吴俊贤 | Medicine ointment for treating psoriasis, as well as preparation method and application thereof |
| CN105381026A (en) * | 2015-12-24 | 2016-03-09 | 兰州古驰生物科技有限公司 | Traditional Chinese medicine health-care preparation used for conditioning allergic state of skin |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1108810C (en) | 2003-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1108810C (en) | Medicine for treating psoriasis and preparing process thereof | |
| CN103566278B (en) | Cortex torricelliae tiliifoliae | |
| CN107320555A (en) | A kind of pharmaceutical composition with antifatigue effect and its production and use | |
| CN1186075C (en) | Medicines for treating pulmonary tuberculosis | |
| CN1840053A (en) | Medicine for treating arthritis, hyperosteogeny and intervertebral disc protrusion and preparation process thereof | |
| CN102274355A (en) | Externally applied medicament for treating foot-and-mouth disease in pigs | |
| CN105535389A (en) | Traditional Chinese medicinal composition for treating lumbar and cervical bone hyperplasia and preparation method thereof | |
| CN1281228C (en) | Medicine for hyperplasia of mammary glands and its preparation | |
| CN107617003A (en) | A kind of cure scapulohumeral periarthritis rhizoma atractylodis dip and preparation method thereof | |
| CN1739623A (en) | Chinese medicine prepn for treating pain in neck, shoulder, waist and leg | |
| CN106491568A (en) | A kind of marine organisms spray film for treating skin injury and infection and preparation method thereof | |
| CN105596769A (en) | Traditional Chinese medicine for treating scalds, bedsores and hemorrhoid | |
| CN104740443A (en) | Traditional Chinese medicine compound essential oil | |
| CN104524397A (en) | Traditional Chinese medicine composition for assisted rehabilitation of stroke and preparation method of composition | |
| CN104984122A (en) | Chinese herbal medicament for treating tetanus and preparation method thereof | |
| CN109248280A (en) | Traditional Chinese medicine composition for treating emphysema and preparation method thereof | |
| CN1055241C (en) | Medicine for pulmonary tuberculosis and its preparation method | |
| CN104352911B (en) | A kind of composition for treating domestic animal breathing problem and preparation method thereof | |
| CN1048173C (en) | Venereal disease curing powder medicine and method for preparing same | |
| CN1236809C (en) | Trauma treating medicament and method for making same | |
| CN106310172A (en) | Ointment medicine for treating painful diseases and preparing method and use thereof | |
| CN1277559C (en) | Medicine for treating rheumatism and its preparation | |
| CN106620203A (en) | Traditional Chinese medicine composition for treating laminitis of cows | |
| CN1927349A (en) | Traditional Chinese medicine for treating rheumatism and its preparing process | |
| CN101062233A (en) | Powdered medicine for coaptation and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |